ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 241 out of 1111

$501K Total Retail Price of All Prescriptions

Rank: 222 out of 1111

230 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 230 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 6,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 283 213 S3 1 1
LEVOTHYROXINE SODIUM 275 223 2 3
POTASSIUM CHLORIDE 241 224 3 9
SIMVASTATIN 237 205 4 5
FUROSEMIDE 231 203 5 6
METFORMIN HCL 186 142 6 8
OMEPRAZOLE 178 164 7 4
LISINOPRIL 173 136 8 2
SYNTHROID 165 126 9 63
MELOXICAM 157 135 10 18
CITALOPRAM HBR 157 124 10 14
GLIMEPIRIDE 144 100 12 61
NEXIUM 137 69 13 26
HYDROCHLOROTHIAZIDE 121 89 14 11
AMLODIPINE BESYLATE 118 105 15 7
NABUMETONE 116 75 16 146
SUCRALFATE 107 86 17 125
CARVEDILOL 107 107 17 21
TRAMADOL HCL 105 86 19 13
PANTOPRAZOLE SODIUM 94 72 20 50
BUSPIRONE HCL 87 43 21 96
GABAPENTIN 80 57 22 10
JANUVIA 77 58 23 75
AMITRIPTYLINE HCL 77 46 R 23 64
ATORVASTATIN CALCIUM 75 66 25 15
PREDNISONE 75 62 25 48
ATENOLOL 71 65 27 22
LOVASTATIN 71 28 27 41
ROPINIROLE HCL 71 58 27 68
CEFUROXIME 70 61 30 138
CYMBALTA 65 31 31 40
ADVAIR DISKUS 65 57 31 43
SERTRALINE HCL 58 26 33 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 48 34 71
LOSARTAN POTASSIUM 54 53 35 34
CYCLOBENZAPRINE HCL 54 31 R 35 37
DONEPEZIL HCL 54 54 35 25
POLYETHYLENE GLYCOL 3350 54 49 35 45
DIGOXIN 50 50 39 47
WARFARIN SODIUM 50 50 39 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.